AIRE Gene Therapy for APS1
Genetic immunotherapy for a rare and debilitating autoimmune syndrome
Published: 9th March 2021

IP Status
- Know-how based
Seeking
- Development partner
- Commercial partner
- Seeking investment
Genetic immunotherapy for a rare and debilitating autoimmune syndrome